Patsnap Synapse Alternative: Daily Trial Change Monitoring, Self-Serve
Patsnap Synapse is a drug discovery intelligence platform with a real free tier and a demo-quoted Premium plan. DataLookout covers one layer of that job: monitoring ClinicalTrials.gov daily and telling you what changed, with public pricing from $0 to $149 a month.
Synapse Premium is quoted through a demo request. DataLookout pricing is public.
Daily change tracking, a free tier to start, and no sales call.
Who actually looks for a Patsnap Synapse alternative
- An r/biotech thread asking why the enterprise intelligence platforms cost so much got, as its top reply, that the pricing is set for companies, not people; another reply said the curation is what the money buys. Synapse's free tier and DataLookout's free tier both exist for the person that pricing leaves out. (r/biotech thread, August 2025)
- A biotech selecting an intelligence platform found the enterprise options expensive and overkill for a company with a specific focus, and kept free and lower-cost tools on the shortlist. (r/biotech thread, October 2024)
The difference is the job. Synapse's free tier covers occasional discovery lookups; DataLookout's covers a standing daily watch, with the diff of each ClinicalTrials.gov record you watch done for you and emailed to you. Free to start, $49/month for Starter.
Patsnap Synapse vs DataLookout
| Feature | Patsnap Synapse | DataLookout |
|---|---|---|
| Free tier | Yes: 10 searches/month, top 20 results | Yes: 1 sponsor + 1 disease watchlist, free forever |
| Paid pricing | Quoted (request a demo) | $49 or $149/month, public, self-serve |
| Primary focus | Drug discovery intelligence: drugs, targets, patents, deals, literature | Daily change detection on ClinicalTrials.gov |
| Clinical trial data | 1.1 million trials and results | ClinicalTrials.gov (150,000+ trials) |
| Email alerts | Premium plan: up to 1,000 alerts | Built-in on every plan, severity-classified |
| Patent data | 16 million patents | No |
| Setup | Free tier: instant. Premium: demo, then quote | 2 minutes |
What Patsnap Synapse offers
Synapse is built for drug discovery research. Its own product pages (checked August 22, 2026) list 98,000+ drugs and biologics, 46,000+ targets, 1.1 million clinical trials and results, 16 million patents, and 67 million literature references, searchable in natural language. The free tier is real: 10 searches a month with the top 20 results per search, no sales call required. Its plan page lists drug search, competitive landscape, clinical progress and patent search as the jobs it covers.
Where DataLookout fits
Synapse answers "what exists." DataLookout answers what changed in the trials you care about since yesterday. It snapshots the ClinicalTrials.gov records it monitors every day, diffs them against the previous day, and classifies each change (status, enrollment, primary endpoints, interventions, results posting, site counts, completion dates, 12 fields in all) as critical, notable, or minor. Changes arrive as a morning email digest and in a dashboard inbox, on every plan including the free one.
The two free tiers do different jobs: Synapse's covers occasional lookups, DataLookout's covers standing daily watch on 1 sponsor + 1 disease. A team that needs both discovery research and daily competitive awareness can run both.
Which tool fits which job?
DataLookout, if:
The job is knowing when trials change: status flips, moved completion dates, rewritten endpoints, new sites. You want pricing you can see and start on today. You're a small or mid-size biotech, an individual BD professional, or an investor tracking specific sponsors or disease areas.
Synapse, if:
The job is discovery research: patents, targets, drug databases, literature, deals, or Synapse's wider trial coverage. DataLookout does not cover any of that and does not try to.
Frequently asked questions
Related resources
Try DataLookout free
1 sponsor + 1 disease watchlist with daily change detection. Free forever, no credit card.
Get started free